scholarly journals The Value of Cancer Immunotherapy Summit at the 2016 Society for Immunotherapy of Cancer 31st Anniversary Annual Meeting

2017 ◽  
Vol 5 (1) ◽  
Author(s):  
Howard L. Kaufman ◽  
Michael B. Atkins ◽  
Adam P. Dicker ◽  
Heather S. Jim ◽  
Louis P. Garrison ◽  
...  
Keyword(s):  
Cancer Immunotherapy ◽  
Annual Meeting ◽  
Immunotherapy Of Cancer

Integrating Bioinformatics Strategies in Cancer Immunotherapy: Current and Future Perspectives

2020 ◽  
Vol 23 (8) ◽  
pp. 687-698 ◽  
Author(s):  
Houda N. Washah ◽  
Elliasu Y. Salifu ◽  
Opeyemi Soremekun ◽  
Ahmed A. Elrashedy ◽  
Geraldene Munsamy ◽  
...  
Keyword(s):  
Cancer Immunotherapy ◽  
Therapeutic Potential ◽  
Cell Cancer ◽  
Full Potential ◽  
Future Perspectives ◽  
The Past ◽  
Bioinformatics Tools ◽  
Treatment Paradigm ◽  
Immunotherapy Of Cancer ◽  
Significant Attention

For the past few decades, the mechanisms of immune responses to cancer have been exploited extensively and significant attention has been given into utilizing the therapeutic potential of the immune system. Cancer immunotherapy has been established as a promising innovative treatment for many forms of cancer. Immunotherapy has gained its prominence through various strategies, including cancer vaccines, monoclonal antibodies (mAbs), adoptive T cell cancer therapy, and immune checkpoint therapy. However, the full potential of cancer immunotherapy is yet to be attained. Recent studies have identified the use of bioinformatics tools as a viable option to help transform the treatment paradigm of several tumors by providing a therapeutically efficient method of cataloging, predicting and selecting immunotherapeutic targets, which are known bottlenecks in the application of immunotherapy. Herein, we gave an insightful overview of the types of immunotherapy techniques used currently, their mechanisms of action, and discussed some bioinformatics tools and databases applied in the immunotherapy of cancer. This review also provides some future perspectives in the use of bioinformatics tools for immunotherapy.

scholarly journals CIMT 2019: report on the 17th Annual Meeting of the Association for Cancer Immunotherapy

2019 ◽  
Vol 16 (4) ◽  
pp. 808-815 ◽  
Author(s):  
Jan David Beck ◽  
Matthias Birtel ◽  
Erik Haefner ◽  
Isabell Sofia Keil ◽  
Daniel Reidenbach ◽  
...  
Keyword(s):  
Cancer Immunotherapy ◽  
Annual Meeting

scholarly journals Toll-Like Receptor-Based Strategies for Cancer Immunotherapy

2021 ◽  
Vol 2021 ◽  
pp. 1-14
Author(s):  
Saghar Pahlavanneshan ◽  
Ali Sayadmanesh ◽  
Hamidreza Ebrahimiyan ◽  
Mohsen Basiri
Keyword(s):  
Cancer Immunotherapy ◽  
Immune Cells ◽  
Immune Cell ◽  
Cell Types ◽  
Genetically Engineered ◽  
Current Status ◽  
Tlr Signaling ◽  
Functional Roles ◽  
Immunotherapy Of Cancer ◽  
Signaling Components

Toll-like receptors (TLRs) are expressed and play multiple functional roles in a variety of immune cell types involved in tumor immunity. There are plenty of data on the pharmacological targeting of TLR signaling using agonist molecules that boost the antitumor immune response. A recent body of research has also demonstrated promising strategies for improving the cell-based immunotherapy methods by inducing TLR signaling. These strategies include systemic administration of TLR antagonist along with immune cell transfer and also genetic engineering of the immune cells using TLR signaling components to improve the function of genetically engineered immune cells such as chimeric antigen receptor-modified T cells. Here, we explore the current status of the cancer immunotherapy approaches based on manipulation of TLR signaling to provide a perspective of the underlying rationales and potential clinical applications. Altogether, reviewed publications suggest that TLRs make a potential target for the immunotherapy of cancer.

scholarly journals CIMT 2018: Pushing frontiers in cancer immunotherapy — Report on the 16th Annual Meeting of the Association for Cancer Immunotherapy

2018 ◽  
Vol 14 (12) ◽  
pp. 2864-2873
Author(s):  
Jan Beck ◽  
Matthias Birtel ◽  
Daniel Reidenbach ◽  
Nadja Salomon ◽  
Mustafa Diken
Keyword(s):  
Cancer Immunotherapy ◽  
Annual Meeting

scholarly journals Correction to: 33rd Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2018)

2019 ◽  
Vol 7 (1) ◽  
Author(s):  
Sneha Berry ◽  
Nicolas Giraldo ◽  
Peter Nguyen ◽  
Benjamin Green ◽  
Haiying Xu ◽  
...  
Keyword(s):  
Annual Meeting ◽  
Immunotherapy Of Cancer

scholarly journals Defining current gaps in quality measures for cancer immunotherapy: consensus report from the Society for Immunotherapy of Cancer (SITC) 2019 Quality Summit

2020 ◽  
Vol 8 (1) ◽  
pp. e000112 ◽  
Author(s):  
Sara Pai ◽  
David Blaisdell ◽  
Rachel Brodie ◽  
Robert Carlson ◽  
Heidi Finnes ◽  
...  
Keyword(s):  
Cancer Immunotherapy ◽  
Cancer Care ◽  
Expert Panel ◽  
Care Delivery ◽  
Quality Measures ◽  
Quality Measure ◽  
Long Term Outcome ◽  
Quality Cancer Care ◽  
National Quality ◽  
Immunotherapy Of Cancer

BackgroundQuality measures are important because they can help improve and standardize the delivery of cancer care among healthcare providers and across tumor types. In an environment characterized by a rapidly shifting immunotherapeutic landscape and lack of associated long-term outcome data, defining quality measures for cancer immunotherapy is a high priority yet fraught with many challenges.MethodsThus, the Society for Immunotherapy of Cancer convened a multistakeholder expert panel to,first, identify the current gaps in measures of quality cancer care delivery as it relates to immunotherapy and to,second, advance priority concepts surrounding quality measures that could be developed and broadly adopted by the field.ResultsAfter reviewing the existing quality measure landscape employed for immunotherapeutic-based cancer care, the expert panel identified four relevant National Quality Strategy domains (patient safety, person and family-centered care, care coordination and communication, appropriate treatment selection) with significant gaps in immunotherapy-based quality cancer care delivery. Furthermore, these domains offer opportunities for the development of quality measures as they relate to cancer immunotherapy. These four quality measure concepts are presented in this consensus statement.ConclusionsThis work represents a first step toward defining and standardizing quality delivery of cancer immunotherapy in order to realize its optimal application and benefit for patients.

Toward next-generation cancer immunotherapy: 10th Annual Meeting of the Association for Cancer Immunotherapy (CIMT), Mainz, Germany, May 23–25, 2012

2013 ◽  
Vol 62 (5) ◽  
pp. 975-981 ◽  
Author(s):  
Björn-Philipp Kloke ◽  
Sarah Kutscher ◽  
Richard Rae ◽  
Pia Kvistborg ◽  
Cedrik M. Britten ◽  
...  
Keyword(s):  
Cancer Immunotherapy ◽  
Annual Meeting ◽  
Next Generation ◽  
10Th Annual Meeting
Sign in / Sign up

Export Citation Format

Share Document